Slaughter and May, Hong Kong, advised Sands China Ltd. on the deal, while Davis Polk advised the joint book-running managers. Sands China Ltd. (Sands China) announced...
You must be a Standard 1 Year member to access this content.
Davis Polk advised Zylox-Tonbridge Medical Technology Co., Ltd., while Clifford Chance has advised Morgan Stanley, CLSA and other underwriters. Grandall Advised Zylox-Tonbridge. JunHe advised Zylox-Tonbridge. The...
You must be a Standard 1 Year member to access this content.
DLA Piper advised HUTCHMED, while Linklaters and Davis Polk advised the joint sponsors and underwriters on the global offering and listing of HUTCHMED (China) Limited on...
You must be a Standard 1 Year member to access this content.
Davis Polk and Maples and Calder advised CARsgen Therapeutics Holdings Limited, while Herbert Smith Freehills and Zhong Lun advised Goldman Sachs and UBS on the deal....
You must be a Standard 1 Year member to access this content.
Davis Polk advised Zai Lab Limited in the deal, while Simpson Thacher represented the underwriters. Zai Lab Limited executed its offering of 5,492,400 American depositary shares,...
You must be a Standard 1 Year member to access this content.
Davis Polk advised the representatives of the underwriters on the offering. Certain selling shareholders of I-Mab issued $177 million SEC-registered follow-on secondary offering of 3,283,950 American depositary...
You must be a Standard 1 Year member to access this content.
